Moneycontrol PRO
glenmark life sciences
Jump to
25 Results Found
  • Bulk Deals | Polar Capital buys 8.6 lakh shares in Glenmark Life, HSBC picks 1.44 lakh shares in Rolex Rings Aug 09, 2021 11:05 PM IST

    Bulk Deals | Polar Capital buys 8.6 lakh shares in Glenmark Life, HSBC picks 1.44 lakh shares in Rolex Rings

    TCG Funds Fund 1 bought 1.26 lakh equity shares in Zeal Aqua at Rs 158 per share on the BSE.

  • Glenmark Life Sciences shares close with 4% gain in debut trade Aug 07, 2021 12:21 AM IST

    Glenmark Life Sciences shares close with 4% gain in debut trade

    The company's market valuation was at Rs 9,167.48 crore on the BSE.

  • Glenmark Life Sciences spikes 11% in early trade on listing day; what should investors do now? Aug 06, 2021 02:10 PM IST

    Glenmark Life Sciences spikes 11% in early trade on listing day; what should investors do now?

    Glenmark Life Sciences IPO shares: Experts say that shareholders who subscribed for listing gains can book profits now, but the stock also has good long-term prospects, given its strong fundamentals

  • Glenmark Life Sciences IPO: Shares list at just 4% premium over issue price Aug 06, 2021 10:00 AM IST

    Glenmark Life Sciences IPO: Shares list at just 4% premium over issue price

    Glenmark Life Sciences' initial public offering had received strong response from investors as the offer was subscribed 44.17 times during July 27-29, 2021.

  • Glenmark Life Sciences IPO debuts on the Street today. What to expect from the listing? Aug 05, 2021 04:30 PM IST

    Glenmark Life Sciences IPO debuts on the Street today. What to expect from the listing?

    Listing gain seems to be justified as the issue was reasonably priced when compared to other listed peers and given the healthy prospects of the API going forward, said Prashanth Tapse of Mehta Equities.

  • Glenmark Life Sciences IPO share allotment finalised: How to check status Aug 04, 2021 08:44 AM IST

    Glenmark Life Sciences IPO share allotment finalised: How to check status

    Glenmark Life Sciences IPO: Investors can check allotment status either on the BSE website or IPO register's website

  • Glenmark Life Sciences IPO share allotment likely today: How to check status Aug 03, 2021 08:47 AM IST

    Glenmark Life Sciences IPO share allotment likely today: How to check status

    Glenmark Life Sciences IPO: The shares of Glenmark Life Sciences will start trading on both BSE and NSE from August 6.

  • Glenmark Life Sciences IPO share allotment expected next week Jul 30, 2021 01:19 PM IST

    Glenmark Life Sciences IPO share allotment expected next week

    After the finalisation of the basis of allotment, funds will be refunded or unblocked from ASBA account on August 4 and shares will be credited to the demat accounts of allottees on August 5

  • Glenmark Life Sciences IPO subscribed 44.17 times on final day, QIB portion booked 36.97 times Jul 29, 2021 11:29 AM IST

    Glenmark Life Sciences IPO subscribed 44.17 times on final day, QIB portion booked 36.97 times

    Glenmark Life is planning to raise Rs 1,513.6 crore through its IPO, which comprises a fresh issue for Rs 1,060 crore and an offer for sale of 63 lakh equity shares by Glenmark Pharma

  • Glenmark Life Sciences IPO oversubscribed by 5.77 times on day 1, retail portion booked 9.25 times Jul 28, 2021 11:42 AM IST

    Glenmark Life Sciences IPO oversubscribed by 5.77 times on day 1, retail portion booked 9.25 times

    Considering the business growth outlook and almost stable operating margins, Choice Broking assigned a 'subscribe' rating to the issue.

  • Subscribe to Glenmark Life Sciences: Geojit Jul 27, 2021 01:43 PM IST

    Subscribe to Glenmark Life Sciences: Geojit

    Geojit has come out with its report on Glenmark Life Sciences. The research firm has recommended to ''Subscribe'' the ipo in its research report as on July 24, 2021.

  • Subscribe to Glenmark Life Sciences: Ajcon Global Jul 27, 2021 01:38 PM IST

    Subscribe to Glenmark Life Sciences: Ajcon Global

    Ajcon Global has come out with its report on Glenmark Life Sciences. The research firm has recommended to ''Subscribe'' the ipo in its research report as on July 26, 2021.

  • Subscribe to Glenmark Life Sciences: Arihant Capital Jul 27, 2021 01:30 PM IST

    Subscribe to Glenmark Life Sciences: Arihant Capital

    Arihant Capital has come out with its report on Glenmark Life Sciences. The research firm has recommended to ''Subscribe'' the ipo in its research report as on July 26, 2021.

  • Subscribe to Glenmark Life Sciences: Choice Equity Broking Jul 27, 2021 01:24 PM IST

    Subscribe to Glenmark Life Sciences: Choice Equity Broking

    Choice Equity Broking has come out with its report on Glenmark Life Sciences. The research firm has recommended to ''Subscribe'' the ipo in its research report as on July 23, 2021.

  • Glenmark Life Sciences IPO subscribed 2.78 times on day 1, retail portion booked 5.16 times Jul 27, 2021 11:27 AM IST

    Glenmark Life Sciences IPO subscribed 2.78 times on day 1, retail portion booked 5.16 times

    The subsidiary of Glenmark Pharma plans to raise Rs 1,513.6 crore through the public issue which comprises a fresh issue of Rs 1,060 crore, and an offer for sale of 63 lakh equity shares by promoter.

  • Glenmark Life Sciences IPO: Traction in complex APIs holds re-rating potential Jul 27, 2021 09:47 AM IST

    Glenmark Life Sciences IPO: Traction in complex APIs holds re-rating potential

    In order to address the opportunities in oncology, peptides and iron compounds, Glenmark Life Science plans to build an R&D pipeline in the coming years

  • Glenmark Life Sciences IPO opens today, should you subscribe? Jul 27, 2021 09:26 AM IST

    Glenmark Life Sciences IPO opens today, should you subscribe?

    Glenmark Life Sciences IPO: The company has debt-to-equity of 1.3x with a debt of Rs 916 crore which includes Rs 800 crore payable to Glenmark Pharmaceuticals, post-IPO debt will be negligible.

  • Glenmark Life Sciences mobilises Rs 454 crore from anchor investors ahead of IPO Jul 26, 2021 10:05 PM IST

    Glenmark Life Sciences mobilises Rs 454 crore from anchor investors ahead of IPO

    Proceeds from the fresh issue will be used towards payment of outstanding purchase consideration to the promoter for the spin-off of the API business and funding the capital expenditure requirements.

  • IPO corner | Rolex Rings versus Glenmark Life Science: Which one should you subscribe? Jul 26, 2021 12:39 PM IST

    IPO corner | Rolex Rings versus Glenmark Life Science: Which one should you subscribe?

    The primary market is abuzz in 2021. This week, two companies - Glenmark Life Sciences and Rolex Rings - have launched their maiden public issue. Read on to know which one market experts prefer if you need to choose one of the two

  • Subscribe to Glenmark Life Sciences: Anand Rathi Jul 26, 2021 07:52 AM IST

    Subscribe to Glenmark Life Sciences: Anand Rathi

    Anand Rathi has come out with its report on Glenmark Life Sciences. The research firm has recommended to ''Subscribe'' the ipo in its research report as on July 23, 2021.

  • Glenmark Life Sciences IPO opens tomorrow: Issue size, price, lot size, company financials and other details Jul 22, 2021 09:35 AM IST

    Glenmark Life Sciences IPO opens tomorrow: Issue size, price, lot size, company financials and other details

    Glenmark Life Sciences IPO: The company plans to raise Rs 1,497.85 crore at the lower end and Rs 1,513.6 crore at the higher end of the price band.

  • Glenmark Life Sciences IPO price band fixed at Rs 695-720, to raise Rs 1,513.6 crore Jul 21, 2021 08:21 AM IST

    Glenmark Life Sciences IPO price band fixed at Rs 695-720, to raise Rs 1,513.6 crore

    Glenmark Life IPO: The IPO comprises a fresh issue of Rs 1,060 crore and an offer for sale of 63 lakh equity shares by promoter Glenmark Pharmaceuticals

  • Glenmark Pharma’s API Arm Glenmark Life Sciences may launch IPO in July to raise up to Rs 1,700 crore Jun 18, 2021 03:17 PM IST

    Glenmark Pharma’s API Arm Glenmark Life Sciences may launch IPO in July to raise up to Rs 1,700 crore

    The management has indicated that the API growth outlook remains strong for the next two-three years owing to a favourable demand-supply scenario.

  • Utkarsh Small Finance Bank, Glenmark Life Sciences get Sebi's go ahead to float IPO Jun 08, 2021 06:10 PM IST

    Utkarsh Small Finance Bank, Glenmark Life Sciences get Sebi's go ahead to float IPO

    Utkarsh Small Finance Bank and Glenmark Life Science had filed preliminary IPO papers with Sebi in March and April respectively.

  • Glenmark Pharma’s API arm files papers with Sebi to unlock value via IPO Apr 17, 2021 12:27 PM IST

    Glenmark Pharma’s API arm files papers with Sebi to unlock value via IPO

    Two years ago, Glenmark Pharmaceuticals had attempted to sell a minority stake in its API business to private equity funds but those plans did not fructify. Post the Q3FY21 results, the management indicated that API growth outlook remained strong for the next two-three years owing to a favourable demand-supply scenario.

Sections
ISO 27001 - BSI Assurance Mark